202
Participants
Start Date
October 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
ABT-652 NSAID
ABT-652 capsules - 2 ABT-652 capsules twice daily (add-on) NSAID- as prescribed
Placebo NSAID
Placebo - 2 placebo capsules twice daily NSAID- as prescribed
Site Reference ID/Investigator# 61238, Duncansville
Site Reference ID/Investigator# 61223, Salisbury
Site Reference ID/Investigator# 61263, Marietta
Site Reference ID/Investigator# 61234, DeLand
Site Reference ID/Investigator# 61217, Orlando
Site Reference ID/Investigator# 61231, Plantation
Site Reference ID/Investigator# 61245, Tampa
Site Reference ID/Investigator# 61213, Ocala
Site Reference ID/Investigator# 61211, Oldsmar
Site Reference ID/Investigator# 61273, Cincinnati
Site Reference ID/Investigator# 61269, Franklin
Site Reference ID/Investigator# 61244, Florissant
Site Reference ID/Investigator# 61266, St Louis
Site Reference ID/Investigator# 61206, Omaha
Site Reference ID/Investigator# 61228, Oklahoma City
Site Reference ID/Investigator# 61205, Beaumont
Site Reference ID/Investigator# 61218, Bryan
Site Reference ID/Investigator# 61235, San Antonio
Site Reference ID/Investigator# 61232, Draper
Site Reference ID/Investigator# 61226, Phoenix
Site Reference ID/Investigator# 61221, Phoenix
Site Reference ID/Investigator# 61241, Tucson
Site Reference ID/Investigator# 61204, Long Beach
Site Reference ID/Investigator# 61258, North Hollywood
Site Reference ID/Investigator# 61242, La Mesa
Site Reference ID/Investigator# 61257, Anaheim
Site Reference ID/Investigator# 61246, Fresno
Site Reference ID/Investigator# 61264, Portland
Site Reference ID/Investigator# 61265, Milford
Site Reference ID/Investigator# 61210, Brockton
Site Reference ID/Investigator# 61260, Watertown
AbbVie (prior sponsor, Abbott)
INDUSTRY